Jump Financial, LLC Sangamo Therapeutics, Inc Transaction History

Jump Financial, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.32 - $1.1 $8,442 - $29,021	-26,383 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$0.36 - $0.65 $9,497 - $17,148	26,383 New	26,383 $9,000
Q4 2022 Feb 13, 2023	SELL	$2.77 - $5.07 $72,011 - $131,804	-25,997 Reduced 21.17%	96,809 $303,000
Q3 2022 Nov 07, 2022	SELL	$4.27 - $6.39 $105,328 - $157,622	-24,667 Reduced 16.73%	122,806 $602,000
Q2 2022 Aug 09, 2022	BUY	$3.28 - $6.21 $483,711 - $915,807	147,473 New	147,473 $610,000
Q1 2021 May 17, 2021	SELL	$10.88 - $17.05 $368,832 - $577,995	-33,900 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$9.23 - $18.18 $80,734 - $159,020	-8,747 Reduced 20.51%	33,900 $529,000
Q3 2020 Nov 13, 2020	BUY	$9.38 - $12.48 $400,028 - $532,234	42,647 New	42,647 $403,000

114

56.3M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $321M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.